Via Softpedia :
" A variety of drug-resistant viruses may have just found their match, researchers at the US Centers for Disease Control and Prevention (CDC) say. Working in collaboration with colleagues from the University of Buffalo, the experts managed to devise a new means of delivering a drug payload to cells that relies on using nanoparticles.
The active agent, which will play an important role in boosting the function of the immune system as infections occur, will be carried by gold nanorods. These structures have proven to be extremely well suited for the job, and researchers obtained numerous successes using them in laboratory tests.
“This joint research by UB and the CDC has the potential to usher in a new generation of antiviral medicines to aggressively treat a broad range of infectious diseases, from H1N1 to avian flu and perhaps Ebola, that are becoming increasingly resistant to the medicines used against them,” explains the executive director of the UB Institute for Lasers, Photonics and Biophotonics (ILPB), Paras Prasad, PhD, the leader of the research team at the university."
No comments:
Post a Comment